Goodhand, JR
19  results:
Search for persons X
?
 
?
4

Neutralising antibody potency against SARS-CoV-2 wild-type ..:

Liu, Z ; Le, K ; Zhou, X...
https://openaccess.sgul.ac.uk/id/eprint/115739/1/1-s2.0-S2468125322003892-main.pdf.  , 2023
 
?
5

Implications for sequencing of biologic therapy and choice ..:

Chanchlani, N ; Lin, S ; Auth, MK...
https://openaccess.sgul.ac.uk/id/eprint/114741/1/Aliment%20Pharmacol%20Ther%20-%202022%20-%20Chanchlani%20-%20Implications%20for%20sequencing%20of%20biologic%20therapy%20and%20choice%20of%20second%20anti%E2%80%90TNF.pdf.  , 2022
 
?
6

Implications for sequencing of biologic therapy and choice ..:

Chanchlani, N ; Lin, S ; Auth, MK...
https://discovery.ucl.ac.uk/id/eprint/10155718/1/Implications%20for%20sequencing%20of%20biologic%20therapy.pdf.  , 2022
 
?
7

Vaccine escape, increased breakthrough and reinfection in i..:

Kennedy, NA ; Janjua, M ; Chanchlani, N...
https://openaccess.sgul.ac.uk/id/eprint/114625/1/CLARITY%203rd%20dose%20paper%20-%20clean%20revision%20with%20figures.docx.  , 2022
 
?
10

Infliximab is associated with attenuated immunogenicity to ..:

Kennedy, NA ; Lin, S ; Goodhand, JR...
https://openaccess.sgul.ac.uk/id/eprint/113201/1/CLARITY%20vaccine%20revision%20clean%20-%20manuscript.docx.  , 2021
 
?
11

Anti-SARS-CoV-2 antibody responses are attenuated in patien..:

Kennedy, NA ; Goodhand, JR ; Bewshea, C...
https://openaccess.sgul.ac.uk/id/eprint/113076/1/R1%20CLARITY%20II%20manuscript%20Gut.docx.  , 2021
 
?
12

HLA-DQA1*05 Carriage Associated With Development of Anti-Dr..:

Sazonovs, A ; Kennedy, NA ; Moutsianas, L...
https://openaccess.sgul.ac.uk/id/eprint/111605/1/1-s2.0-S0016508519414145-main.pdf.  , 2020
 
?
14

Predictors of anti-TNF treatment failure in anti-TNF-naive ..:

Kennedy, NA ; Heap, GA ; Green, HD...
https://openaccess.sgul.ac.uk/id/eprint/111622/1/PANTS%20LGH%20R3%20changes%20accepted.docx.  , 2019
 
1-15